NKF Appoints Morgan Stanley Executive to National Board~Valerie Dixon-Joins the Kidney Disease Fight~

(April 6, 2023, New York, NY) — The National Kidney Foundation (NKF) is excited announce the appointment of Valerie Dixon, Managing Director in the Healthcare Investment Banking Group at Morgan Stanley, to its National Board of Directors. Dixon was nominated and approved at NKF’s most recent Board meeting held in March.

“We’re thrilled Valerie has joined the NKF Board of Directors and will bring a wealth of corporate finance expertise to the board,” said Tracy McKibben, Chair of NKF’s National Board and a living kidney donor to her mother. With 16 years of corporate finance experience, Valerie has served as a trusted advisor to C-suite executives and numerous boards on a range of strategic and financial matters including mergers and acquisitions, and debt and equity financing. We look forward to working with Valerie as we continue to build greater awareness of kidney disease and ways to achieve optimal kidney health.” 

Valerie Dixon resides in New York, NY, and has extensive experience with corporate finance, mergers, and acquisitions for a variety of healthcare clients and industrial conglomerates.

Prior to joining Morgan Stanley, Dixon was an Executive Director in J.P. Morgan’s Healthcare Investment Banking group. Previously, she spent eight years with Citigroup and Lehman Brothers, in roles of increasing responsibility including as a sell-side Research Analyst covering emerging medical technology, life science tools, and diagnostics sectors. Dixon earned an MBA from Yale School of Management and is a graduate of Harvard College. She also serves on the Board of The Metropolitan Opera.

“It’s such an honor to join the NKF Board of Directors because I know how devastating kidney disease is through the lens of my clients who are medical device entrepreneurs that I provide investment banking advice to,” said Valerie Dixon, Managing Director at Morgan Stanley. “My clients are developing new, exciting innovations for the diagnosis and treatment of all kinds of chronic diseases, including kidney disease. It’s important to me that I do my part to help the 37 million Americans estimated to have this challenging disease.”

For more information about kidney disease, visit www.kidney.org

About Kidney Disease

In the United States, more than 37 million adults are estimated to have kidney disease, also known as chronic kidney disease (CKD)—and approximately 90 percent don’t know they have it. About 1 in 3 adults in the U.S. are at risk for kidney disease. Risk factors for kidney disease include: diabeteshigh blood pressureheart diseaseobesity, and family history. People of Black or African American, Hispanic or Latino, American Indian or Alaska Native, Asian American, or Native Hawaiian or Other Pacific Islander descent are at increased risk for developing the disease. Black or African American people are about four times as likely as White people to have kidney failure. Hispanics experience kidney failure at about double the rate of White people.

About National Kidney Foundation

The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org